OUTLOOK THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Basic Shares Outstanding (Weighted Average) of 136.74 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-18
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 136.74M shares, a 270.01% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 81.84M shares, a 165.06% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 60.21M shares, a 148.43% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 47.19M shares, a 98.90% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 34.80M shares, a 87.59% increase from fiscal 2024.
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 18.55M shares, a 48.29% increase from fiscal 2023.
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 12.51M shares, a 94.10% decline from fiscal 2022.
- OUTLOOK THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 212.08M shares, a 38.91% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 136.74M shares 10-Q · filed 2026-08-18 | 109.29M shares derived: average of 2 quarters · filed 2026-08-18 | 93.23M shares 10-Q · filed 2026-08-18 | 81.49M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2026-03-31 | 81.84M shares 10-Q · filed 2026-05-15 | 70.90M shares 10-Q · filed 2026-05-15 | 63.08M shares derived: average of 3 quarters · filed 2026-05-15 | 56.55M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2025-12-31 | 60.21M shares 10-Q · filed 2026-02-17 | 53.70M shares derived: average of 2 quarters · filed 2026-02-17 | 48.12M shares derived: average of 3 quarters · filed 2026-08-18 | 43.81M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2025-09-30 | 47.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | 42.07M shares derived: average of 2 quarters · filed 2026-08-18 | 38.34M shares derived: average of 3 quarters · filed 2026-08-18 | 34.80M shares 10-K · filed 2025-12-19 | ||||
| 2025-06-30 | 36.96M shares 10-Q · filed 2026-08-18 | 33.92M shares derived: average of 2 quarters · filed 2026-08-18 | 30.66M shares 10-Q · filed 2026-08-18 | 28.95M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2025-03-31 | 30.87M shares 10-Q · filed 2026-05-15 | 27.52M shares 10-Q · filed 2026-05-15 | 26.28M shares derived: average of 3 quarters · filed 2026-05-15 | 25.52M shares derived: average of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | 24.23M shares 10-Q · filed 2026-02-17 | 23.98M shares derived: average of 2 quarters · filed 2026-02-17 | 23.73M shares derived: average of 3 quarters · filed 2026-02-17 | 21.36M shares derived: average of 4 quarters · filed 2026-02-17 | ||||
| 2024-09-30 | 23.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-19 | 23.48M shares derived: average of 2 quarters · filed 2025-12-19 | 20.41M shares derived: average of 3 quarters · filed 2025-12-19 | 18.55M shares 10-K · filed 2025-12-19 | ||||
| 2024-06-30 | 23.23M shares 10-Q · filed 2025-08-14 | 18.75M shares derived: average of 2 quarters · filed 2025-08-14 | 16.82M shares 10-Q · filed 2025-08-14 | 15.88M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 14.27M shares 10-Q · filed 2025-05-15 | 13.64M shares 10-Q · filed 2025-05-15 | 13.43M shares derived: average of 3 quarters · filed 2025-05-15 | 13.28M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 13.01M shares 10-Q · filed 2025-02-14 | 260.26M shares 10-Q · filed 2024-02-14 | 13.01M shares derived: average of 2 quarters · filed 2025-02-14 | 12.95M shares derived: average of 3 quarters · filed 2025-02-14 | 12.92M shares derived: average of 4 quarters · filed 2025-02-14 | |||
| 2023-09-30 | 13.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | 12.92M shares derived: average of 2 quarters · filed 2024-12-27 | 12.89M shares derived: average of 3 quarters · filed 2024-12-27 | 12.51M shares 10-K · filed 2024-12-27 | 250.18M shares 10-K · filed 2023-12-22 | |||
| 2023-06-30 | 12.84M shares 10-Q · filed 2024-08-14 | 256.88M shares 10-Q · filed 2023-08-14 | 12.84M shares derived: average of 2 quarters · filed 2024-08-14 | 12.34M shares 10-Q · filed 2024-08-14 | 246.88M shares 10-Q · filed 2023-08-14 | 118.52M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 12.83M shares 10-Q · filed 2024-05-15 | 256.67M shares 10-Q · filed 2023-05-15 | 12.09M shares 10-Q · filed 2024-05-15 | 241.88M shares 10-Q · filed 2023-05-15 | 153.75M shares derived: average of 3 quarters · filed 2024-05-15 | 170.43M shares derived: average of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | 227.41M shares 10-Q · filed 2024-02-14 | 224.20M shares derived: average of 2 quarters · filed 2024-02-14 | 222.97M shares derived: average of 3 quarters · filed 2024-02-14 | 221.99M shares derived: average of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | 220.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-22 | 220.75M shares derived: average of 2 quarters · filed 2023-12-22 | 220.19M shares derived: average of 3 quarters · filed 2023-12-22 | 212.08M shares 10-K · filed 2023-12-22 | ||||
| 2022-06-30 | 220.50M shares 10-Q · filed 2023-08-14 | 219.78M shares derived: average of 2 quarters · filed 2023-08-14 | 209.11M shares 10-Q · filed 2023-08-14 | 199.46M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 219.07M shares 10-Q · filed 2023-05-15 | 203.44M shares 10-Q · filed 2023-05-15 | 192.45M shares derived: average of 3 quarters · filed 2023-05-15 | 186.44M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 188.16M shares 10-Q · filed 2023-02-14 | 179.14M shares derived: average of 2 quarters · filed 2023-02-14 | 175.57M shares derived: average of 3 quarters · filed 2023-02-14 | 169.36M shares derived: average of 4 quarters · filed 2023-02-14 | ||||
| 2021-09-30 | 170.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-29 | 169.27M shares derived: average of 2 quarters · filed 2022-12-29 | 163.09M shares derived: average of 3 quarters · filed 2022-12-29 | 152.68M shares 10-K · filed 2022-12-29 | ||||
| 2021-06-30 | 168.42M shares 10-Q · filed 2022-08-10 | 159.58M shares derived: average of 2 quarters · filed 2022-08-10 | 146.86M shares 10-Q · filed 2022-08-10 | 140.71M shares derived: average of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | 150.73M shares 10-Q · filed 2022-05-13 | 136.08M shares 10-Q · filed 2022-05-13 | 131.48M shares derived: average of 3 quarters · filed 2022-05-13 | 121.30M shares derived: average of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | 121.75M shares 10-Q · filed 2022-02-14 | 121.85M shares derived: average of 2 quarters · filed 2022-02-14 | 111.49M shares derived: average of 3 quarters · filed 2022-02-14 | |||||
| 2020-09-30 | 121.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | 106.36M shares derived: average of 2 quarters · filed 2021-12-23 | 72.56M shares 10-K · filed 2021-12-23 | |||||
| 2020-06-30 | 90.76M shares 10-Q · filed 2021-08-13 | 56.09M shares 10-Q · filed 2021-08-13 | ||||||
| 2018-09-30 | 72.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | 53.55M shares derived: average of 2 quarters · filed 2018-12-18 | 44.28M shares derived: average of 3 quarters · filed 2018-12-18 | 39.46M shares 10-K · filed 2018-12-18 | ||||
| 2018-06-30 | 34.54M shares 10-Q · filed 2018-08-14 | 30.14M shares derived: average of 2 quarters · filed 2018-08-14 | 28.42M shares 10-Q · filed 2018-08-14 | |||||
| 2018-03-31 | 25.73M shares 10-Q · filed 2018-05-15 | 25.36M shares 10-Q · filed 2018-05-15 | ||||||
| 2017-09-30 | 24.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | 24.58M shares derived: average of 2 quarters · filed 2018-12-18 | 24.30M shares derived: average of 3 quarters · filed 2018-12-18 | 24.02M shares 10-K · filed 2018-12-18 | ||||
| 2017-06-30 | 24.44M shares 10-Q · filed 2018-08-14 | 24.08M shares derived: average of 2 quarters · filed 2018-08-14 | 23.79M shares 10-Q · filed 2018-08-14 | |||||
| 2017-03-31 | 23.72M shares 10-Q · filed 2018-05-15 | 23.46M shares 10-Q · filed 2018-05-15 | ||||||
| 2016-09-30 | 22.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | 20.83M shares derived: average of 2 quarters · filed 2017-12-29 | 18.61M shares derived: average of 3 quarters · filed 2017-12-29 | 17.21M shares 10-K · filed 2017-12-29 | ||||
| 2016-06-30 | 18.82M shares 10-Q · filed 2017-08-14 | 16.49M shares derived: average of 2 quarters · filed 2017-08-14 | 15.34M shares 10-Q · filed 2017-08-14 | |||||
| 2016-03-31 | 14.16M shares 10-Q · filed 2017-05-15 | 13.61M shares 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |